• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
成果搜索

author:

Xu, H. (Xu, H..) [1] | Zhang, X. (Zhang, X..) [2] | Cai, Z. (Cai, Z..) [3] | Dong, X. (Dong, X..) [4] | Chen, G. (Chen, G..) [5] | Li, Z. (Li, Z..) [6] | Qiu, L. (Qiu, L..) [7] | He, L. (He, L..) [8] | Liang, B. (Liang, B..) [9] | Liu, X. (Liu, X..) [10] | Liu, J. (Liu, J..) [11]

Indexed by:

Scopus

Abstract:

Tuberculosis is one of the most serious infectious diseases, resulting in death worldwide. Traditional detection methods are not enough to meet the clinical requirements of rapid diagnosis, high specificity, and high sensitivity. Fast, sensitive, and accurate detection of Mycobacterium tuberculosis (MTB) is urgently needed to treat and control tuberculosis disease. Clustered regularly interspaced short palindromic repeats (CRISPR)–associated proteins (Cas12a) exhibit strong nonspecific degradation ability of exogenous single-strand nucleic acids (trans cleavage) after specific recognition of target sequence. We purified Cas12a protein and selected a proper guide RNA based on conserved sequences of MTB from designed guide RNA library. Then, we proposed a novel detection method based on recombinase polymerase amplification and CRISPR/Cas12a nuclease system for specific and sensitive detection of MTB DNA. The assay, based on fluorescence detection, showed 4.48 fmol/L of limit of detection and good linear correlation of concentration with fluorescence value (R2 = 0.9775). It also showed good performance in distinguishing other bacteria. Furthermore, its clinical performance was evaluated by 193 samples and showed sensitivity of 99.29% (139/140) and specificity of 100% (53/53) at 99% CI, compared with culture method. Taken together, the CRISPR/Cas12a system showed good specificity, excellent sensitivity, and excellent accuracy for MTB detection, and it meets requirements of MTB detection in clinical samples and has great potential for clinical translation. © 2020 Association for Molecular Pathology and American Society for Investigative Pathology

Keyword:

Community:

  • [ 1 ] [Xu, H.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 2 ] [Xu, H.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 3 ] [Zhang, X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 4 ] [Zhang, X.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 5 ] [Cai, Z.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 6 ] [Cai, Z.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 7 ] [Cai, Z.]School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China
  • [ 8 ] [Dong, X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 9 ] [Dong, X.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 10 ] [Chen, G.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 11 ] [Chen, G.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 12 ] [Chen, G.]School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China
  • [ 13 ] [Li, Z.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 14 ] [Li, Z.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 15 ] [Qiu, L.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 16 ] [Qiu, L.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 17 ] [He, L.]College of Biological Science and Engineering, Fuzhou University, Fuzhou, China
  • [ 18 ] [Liang, B.]Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
  • [ 19 ] [Liu, X.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 20 ] [Liu, X.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 21 ] [Liu, X.]School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China
  • [ 22 ] [Liu, J.]The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China
  • [ 23 ] [Liu, J.]Mengchao Med-X Center, Fuzhou University, Fuzhou, China
  • [ 24 ] [Liu, J.]Liver Disease Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

Reprint 's Address:

  • [Liu, X.]Mengchao Hepatobiliary Hospital of Fujian Medical UniversityChina

Show more details

Related Keywords:

Related Article:

Source :

Journal of Molecular Diagnostics

ISSN: 1525-1578

Year: 2020

Issue: 8

Volume: 22

Page: 1020-1029

5 . 5 6 8

JCR@2020

3 . 4 0 0

JCR@2023

ESI HC Threshold:142

JCR Journal Grade:1

CAS Journal Grade:2

Cited Count:

WoS CC Cited Count:

SCOPUS Cited Count:

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 1

Affiliated Colleges:

Online/Total:79/10461221
Address:FZU Library(No.2 Xuyuan Road, Fuzhou, Fujian, PRC Post Code:350116) Contact Us:0591-22865326
Copyright:FZU Library Technical Support:Beijing Aegean Software Co., Ltd. 闽ICP备05005463号-1